EP0273962A1 - Compositions for the prolonged action of anti-plaque agents - Google Patents
Compositions for the prolonged action of anti-plaque agentsInfo
- Publication number
- EP0273962A1 EP0273962A1 EP87904629A EP87904629A EP0273962A1 EP 0273962 A1 EP0273962 A1 EP 0273962A1 EP 87904629 A EP87904629 A EP 87904629A EP 87904629 A EP87904629 A EP 87904629A EP 0273962 A1 EP0273962 A1 EP 0273962A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- composition
- composition according
- weight
- surfactant
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 287
- 230000002882 anti-plaque Effects 0.000 title description 17
- 230000009471 action Effects 0.000 title description 5
- 230000002035 prolonged effect Effects 0.000 title description 4
- 239000004094 surface-active agent Substances 0.000 claims abstract description 58
- 239000000551 dentifrice Substances 0.000 claims abstract description 52
- 150000001558 benzoic acid derivatives Chemical class 0.000 claims abstract description 28
- 150000003839 salts Chemical class 0.000 claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 23
- 239000006072 paste Substances 0.000 claims abstract description 13
- 239000000126 substance Substances 0.000 claims abstract description 12
- 239000003599 detergent Substances 0.000 claims abstract description 11
- 239000000606 toothpaste Substances 0.000 claims abstract description 7
- 229940034610 toothpaste Drugs 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 50
- 239000007937 lozenge Substances 0.000 claims description 47
- 239000000796 flavoring agent Substances 0.000 claims description 40
- 235000019634 flavors Nutrition 0.000 claims description 40
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 34
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 31
- 239000000600 sorbitol Substances 0.000 claims description 31
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 29
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 29
- 239000004299 sodium benzoate Substances 0.000 claims description 29
- 235000010234 sodium benzoate Nutrition 0.000 claims description 29
- 239000000499 gel Substances 0.000 claims description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 230000002421 anti-septic effect Effects 0.000 claims description 23
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 claims description 22
- 239000003139 biocide Substances 0.000 claims description 22
- 229960004025 sodium salicylate Drugs 0.000 claims description 22
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 21
- 239000000253 Denture Cleanser Substances 0.000 claims description 21
- 239000004014 plasticizer Substances 0.000 claims description 20
- -1 benzoic acid salt Chemical class 0.000 claims description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000011230 binding agent Substances 0.000 claims description 18
- 230000003115 biocidal effect Effects 0.000 claims description 16
- 239000000945 filler Substances 0.000 claims description 16
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 15
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 15
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 14
- 150000001875 compounds Chemical class 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 14
- 239000003082 abrasive agent Substances 0.000 claims description 13
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical group [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- 239000005711 Benzoic acid Substances 0.000 claims description 11
- 235000010233 benzoic acid Nutrition 0.000 claims description 11
- 239000004067 bulking agent Substances 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 11
- 150000007524 organic acids Chemical class 0.000 claims description 10
- 244000215068 Acacia senegal Species 0.000 claims description 9
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 9
- 229920000084 Gum arabic Polymers 0.000 claims description 9
- 235000010489 acacia gum Nutrition 0.000 claims description 9
- 229910021538 borax Inorganic materials 0.000 claims description 9
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 9
- 239000003086 colorant Substances 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 8
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical group [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 claims description 8
- 235000006491 Acacia senegal Nutrition 0.000 claims description 7
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 7
- 241000416162 Astragalus gummifer Species 0.000 claims description 7
- 229920001615 Tragacanth Polymers 0.000 claims description 7
- 229960000458 allantoin Drugs 0.000 claims description 7
- 239000008122 artificial sweetener Substances 0.000 claims description 7
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 229960003260 chlorhexidine Drugs 0.000 claims description 7
- 239000007789 gas Substances 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- JRKICGRDRMAZLK-UHFFFAOYSA-L peroxydisulfate Chemical compound [O-]S(=O)(=O)OOS([O-])(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 claims description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 235000010487 tragacanth Nutrition 0.000 claims description 6
- 229940116362 tragacanth Drugs 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 239000013003 healing agent Substances 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 239000000196 tragacanth Substances 0.000 claims description 5
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000011775 sodium fluoride Substances 0.000 claims description 4
- 235000013024 sodium fluoride Nutrition 0.000 claims description 4
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 4
- 239000003929 acidic solution Substances 0.000 claims description 3
- 125000002091 cationic group Chemical group 0.000 claims description 2
- 229920001206 natural gum Polymers 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 abstract description 28
- 230000001680 brushing effect Effects 0.000 abstract description 22
- 239000004615 ingredient Substances 0.000 description 56
- 235000015218 chewing gum Nutrition 0.000 description 41
- 229940112822 chewing gum Drugs 0.000 description 38
- 238000009472 formulation Methods 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 229960003885 sodium benzoate Drugs 0.000 description 21
- 235000003599 food sweetener Nutrition 0.000 description 20
- 239000003765 sweetening agent Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 238000002156 mixing Methods 0.000 description 13
- 210000000214 mouth Anatomy 0.000 description 13
- 238000013019 agitation Methods 0.000 description 11
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 9
- 235000015424 sodium Nutrition 0.000 description 8
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 8
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- 239000003981 vehicle Substances 0.000 description 7
- 229940064004 antiseptic throat preparations Drugs 0.000 description 6
- 239000004927 clay Substances 0.000 description 6
- 108010011485 Aspartame Proteins 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 5
- 239000000605 aspartame Substances 0.000 description 5
- 235000010357 aspartame Nutrition 0.000 description 5
- 229960003438 aspartame Drugs 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000003906 humectant Substances 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229920001908 Hydrogenated starch hydrolysate Polymers 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 239000005844 Thymol Substances 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 229960005233 cineole Drugs 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 4
- 229940094522 laponite Drugs 0.000 description 4
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 208000028169 periodontal disease Diseases 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 235000019204 saccharin Nutrition 0.000 description 4
- 229940081974 saccharin Drugs 0.000 description 4
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- 229960000790 thymol Drugs 0.000 description 4
- 229920001285 xanthan gum Polymers 0.000 description 4
- 235000010493 xanthan gum Nutrition 0.000 description 4
- 239000000230 xanthan gum Substances 0.000 description 4
- 229940082509 xanthan gum Drugs 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 208000006558 Dental Calculus Diseases 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000001058 Sterculia urens Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 206010044029 Tooth deposit Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000000872 buffer Chemical class 0.000 description 3
- 230000003139 buffering effect Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000007505 plaque formation Effects 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 229950008882 polysorbate Drugs 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 229960001922 sodium perborate Drugs 0.000 description 3
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 2
- 229940123208 Biguanide Drugs 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000218652 Larix Species 0.000 description 2
- 235000005590 Larix decidua Nutrition 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010029987 Salivary Proteins and Peptides Proteins 0.000 description 2
- 102000001848 Salivary Proteins and Peptides Human genes 0.000 description 2
- 235000015125 Sterculia urens Nutrition 0.000 description 2
- 240000004584 Tamarindus indica Species 0.000 description 2
- 235000004298 Tamarindus indica Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960000892 attapulgite Drugs 0.000 description 2
- 235000012216 bentonite Nutrition 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical class OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
- 229940038472 dicalcium phosphate Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000003349 gelling agent Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052901 montmorillonite Inorganic materials 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 229910052625 palygorskite Inorganic materials 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 240000000896 Dyera costulata Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 244000239659 Eucalyptus pulverulenta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000034619 Gingival inflammation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- VHOQXEIFYTTXJU-UHFFFAOYSA-N Isobutylene-isoprene copolymer Chemical compound CC(C)=C.CC(=C)C=C VHOQXEIFYTTXJU-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588645 Neisseria sicca Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194049 Streptococcus equinus Species 0.000 description 1
- 241000194024 Streptococcus salivarius Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical class OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- DVBJBNKEBPCGSY-UHFFFAOYSA-M cetylpyridinium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 DVBJBNKEBPCGSY-UHFFFAOYSA-M 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000010514 hydrogenated cottonseed oil Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940031993 lithium benzoate Drugs 0.000 description 1
- LDJNSLOKTFFLSL-UHFFFAOYSA-M lithium;benzoate Chemical compound [Li+].[O-]C(=O)C1=CC=CC=C1 LDJNSLOKTFFLSL-UHFFFAOYSA-M 0.000 description 1
- 229940095521 lozenge product Drugs 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- CVPJXKJISAFJDU-UHFFFAOYSA-A nonacalcium;magnesium;hydrogen phosphate;iron(2+);hexaphosphate Chemical compound [Mg+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Fe+2].OP([O-])([O-])=O.OP([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O CVPJXKJISAFJDU-UHFFFAOYSA-A 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 239000012169 petroleum derived wax Substances 0.000 description 1
- 235000019381 petroleum wax Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- JEMLSRUODAIULV-UHFFFAOYSA-M potassium;2-[dodecanoyl(methyl)amino]acetate Chemical compound [K+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O JEMLSRUODAIULV-UHFFFAOYSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229910002028 silica xerogel Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052591 whitlockite Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/43—Guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- This invention relates to improved oral dentifrices and compositions for dental hygiene, and, in particular, to toothpastes and other compositions that enhance plaque removal and prevent plaque buildup.
- Dental plaque is present to some degree, in the form of a film, on virtually all dental surfaces. It is a product of microbial growth, and comprises a dense microbial layer consisting of a mass of microorganisms that may be embedded in a polysaccharide matrix.
- the microorganisms present in plaque include coccoidal organisms, among others, particularly in early plaque, which, in the mouths of some persons at least, may change to filamentous organisms after a few days.
- a wide variety microorganisms are found in the oral cavity, and among these are gram-positive anaerobic rods associated with the development of plaque such as Corynebacterium, Nocardia, Neisseria and Streptococci, such as S. mutens. S. bovis. S. salivarius, and gram- positive streptococci of the genus Peptostreptococcus (See Robert J. Fitzgerald in "The Alabama Journal of Medical Sciences” Volume 5, No. 3, July, 1968, pp. 241- 242) .
- plaque In addition to the aforementioned microorganisms, there is also present in plaque relatively small amounts of other substances such as salivary proteins, carbohydrates, epithelial cells and leucocytes. These organisms play a key role in the etiology of plaque. Some of the bacterial organisms associated with plaque formation produce a capsular material which apparently causes the cells of the organism to adhere to each other, holding the plaque together and allowing for further growth. For example, capsule forming bacteria which occur in large numbers in early plaque are Neisseria sicca and Streptococcus rautans.
- Plaque may form on any part of the tooth surfaces, and is found particularly at the gingival margin, in cracks in the enamel, and on the surface of dental calculus.
- the danger associated with the formation of plaque on the teeth lies in the tendency of plaque to build up, spread, change and eventually produce gingivitis, periodontitis and other types of periodontal disease, as well as dental caries and dental calculus.
- dental plaque is a precursor to the formation of the hard crystalline buildup on teeth referred to as dental calculus.
- calculus which comprises mineralized bacteria a ' s well as organic constituents, such as epithelial cells, live bacteria, salivary proteins, leucocytes, and substances having molecularly bound calcium and phosphorus, e.g., hydroxyapatite, 3[Ca 3 (P0 4 ) 2 ]Ca(OH) 2 octacalciu phosphate, Ca 8 (HP0 4 ) 2 (P0 4 ) 4 .5H 2 ) , brushite, CaHP0 4 .2H 2 0, and whitlockite, which is considered to have the formula beta-Ca 3 (P0 4 ) 2 .
- Dental plaque and, hence, calculus are particularly prone to form at the gingival margin, i.e., the junction of the tooth and gingiva.
- Supragingival plaque i.e., plaque that causes damage above the gingival margin
- subgingival plaque i.e., plaque causing damage below the gingival margine also commonly occur.
- the buildup of plaque at the gingival margin is believed to be a prime cause of gingivitis and other periodontal disorders.
- Regular tooth brushing with a conventional dentifrice for some persons greatly retards or even prevents the accumulation of significant amounts of plaque and calculus.
- compositions containing active anti-plaque ingredients are described herein which, when used in conjunction with a regular regimen of daily toothbrushing, will retard the further development of plaque on dental surfaces.
- Dentifrice compositions effective to remove stains from dental surfaces are also described in this application.
- compositions intended for application to dental surfaces for the purpose of loosening and removing plaque present on the teeth, and retarding the further accumulation of plaque on the treated dental surfaces.
- compositions of the present invention are effective to remove stains from dental surfaces (e.g., natural teeth, synthetic crowns, prosthetic devices or dentures).
- the dentifrice compositions of this invention comprise compositions which include detersive amounts of an oral surfactant and at least 1% by weight of a benzoic acid salt or derivative thereof effective to remove plaque from dental surfaces.
- the combination of the foregoing active ingredients is particularly effective against plaque when used in the compositions of the present invention.
- the compositions of the present invention include a dentifice carrier containing at least 1% by weight of a benzoic acid salt and detersive amounts of an oral surfactant.
- the carrier is any paste, or gel or the like capable of being applied to a toothbrush and brushed onto the teeth.
- the powder compositions of this invention may be adapted for brushing application onto the teeth in the oral cavity or for use on dentures or other synthetic surfaces outside the oral cavity.
- benzoic acid salt we mean any salt which is compatible with the removal of plaque on dental surfaces.
- the benzoic acid should be at least partially water soluble and orally compatible.
- the benzoic acid salt should be at least, partially soluble in the solution used to clean the dental surfaces.
- the particular benzoic acid salt used also must be compatible with the other ingredients in the composition. Examples of particularly useful benzoic acid salts include potassium benzoate, sodium benzoate, and lithium benzoate. Benzoic acid may also be used. It is to be understood that benzoic acid in solution will form a benzoic acid salt in situ as a function of the pH of the solution.
- formulations of the active anti-plaque ingredients include lozenges and chewing gum designed for sustained release of the active anti-plaque ingredients of this invention in the oral cavity over prolonged periods. Such compositions are particularly useful when the brushing of teeth is difficult or impossible.
- the dentifrice compositions comprise a gel or paste carrier which includes detersive amounts of an oral surfactant, at least about 1% by weight of sodium benzoate and preferably, an effective amount of dental abrasive.
- the carrier for the active ingredients may be a gel, paste, powder or the like capable of being applied to a toothbrush and brushed onto the teeth.
- formulations of the above anti-plaque ingredients include at least about 6% by weight sodium benzoate.
- Clay suspensions may be employed in the dentifrice compositions of this invention. These materials can have a marked detersive effect on soiled teeth and dentures by aiding the suspension of the active plaque removing ingredients in dentifrice compositions of this invention. In addition clays may function to absorb some of the bacteria loosened by the other ingredients of the dentifrice.
- a particularly useful synthetic clay material is Laponite XLGTM commercially available from LaPorte Industries, Ltd., London, England, because it can be used to produce dentifrice gels.
- Clay material such as kaolin, the bentonites, montmorillonites, china clay, attapulgite and fuller's earth may be useful as abrasives.
- a number of insoluble inorganic salts may also be used as abrasives, for example dicalcium phosphate, sodium metaphosphate, calcium pyrophosphate, calcium carbonate, magnesium carbonate, and silicates or silicic acid and derivatives thereof, for example, abrasive silica, xerogel, and precipitates. Many of these abrasive compounds are particularly useful in promoting stain removal in embodiments of the present invention. It is to be understood that the abrasives should be compatible with the use of soluble benzoic acid salts, and certain abrasives are to be avoided where their use will result in precipitated or marginally soluble salts of benzoic acid.
- a substantive biocidal agent is employed to enhance the control of plaque.
- Johnson et al. report in "A Review of Chemotherapeutic Plaque Control", ORAL SURG. 47(2): 136-141 (Feb. 1979) that the biguanide chlorhexidine has been demonstrated to successfully control plaque.
- the effectiveness of plaque inhibiting compositions can be enhanced by adding one or more substantive biocides in addition to any other biocides present in the formulation.
- a substantive biocide must be compatible with certain active ingredients in the compositions of the present invention. Specifically, when an anionic surfactant is to be used in certain embodiments of the present invention, it is preferred that the substantive biocide be avoided.
- effective amounts of sodium monofluorophosphate or sodium fluoride may be used to aid in preventing dental caries. This activity is in addition to the separate anti-caries activity which is believed to result from the use of the compositions of this invention to remove plaque from dental surfaces.
- formulations of the dentifrice of this invention may include antiseptically effective amounts of sodium salicylate, an antiseptically active flavorant, e.g., thymol/eucalyptol menthol and a healing agent such as allantoiit.
- an antiseptically active flavorant e.g., thymol/eucalyptol menthol
- a healing agent such as allantoiit.
- the benzoate salt itself imparts antiseptic properties to the formulation.
- compositions containing the foregoing ingredients may serve to sooth gums irritated from brushing, and to actually enhance the rate of healing of gums and associated tissues which may have become irritated during brushing or are due to an existing periodontal disorder such as gingivitis.
- humectants emulsifiers
- bulking agents which can be added to disperse the active ingredients throughout the compositions.
- these humectants and bulking agents aid in providing a gel-like texture to the toothpaste or gel compositions.
- the preferred bulking agents used are organic acids and salts derived therefrom, salts of phosphate, and other buffers, designed to provide bulk and a buffering effect without forming a gel.
- Orally compatible polyhydric alcohols such as sorbitol, mannitol, and hydrogenated starch hydrolysates, for example lycasinTM (available from Poquette Freres, France) are also preferred as bulking agents. These humectants/emulsifiers and bulking agents act to disperse the active ingredients within the dentifrice composition to provide effective anti-plaque activity by maintaining the concentration of -li ⁇ the active ingredients at effective levels throughout the formulation.
- the dentifrice of this invention may be applied to the surface of the teeth by any conventional process, but preferably through the use of a o conventional toothbrush,.
- the dentifrice is preferably applied by placing a comfortable amount of the dentifrice on a tooth brush and then brushing the dentifrice about the teeth and gums with the intention of thoroughly exposing all surfaces of the teeth to the dentifrice of the present invention.
- an amount of a benzoic acid salt and oral surfactant effective to loosen plaque will be incorporated into a chewing gum or lozenge carrier.
- These compositions are designed to administer the active anti-plaque ingredients onto the teeth for a sustained period of time, e.g., when brushing is difficult or impossible.
- these formulations are designed to take advantage of the natural jaw and tongue movement that occurs when chewing gum and lozenge vehicles are used. This movement may aid in uniformly dispersing the active agents of the composition about the dental surfaces.
- the active anti-plaque ingredients be uniformly dispersed in the chewing gum and lozenge vehicles of the present invention. Uniform dispersal of the active ingredients will result in substantially uniform amounts of the active ingredients being released over a prolonged time period. This will increase the duration of time that the teeth will be exposed to the actives and also maximize the likelihood that the active ingredients of the composition will loosen plaque on dental surfaces hard to reach through brushing, e.g., the areas between the teeth normally reached only by flossing. In this manner, these compositions can function as an adjunct to flossing.
- the chewing gum comprises a gum-base carrier, having distributed therein effective amounts of an orally compatible surfactant, and at least about 1% by weight of a benzoic acid salt.
- An active anti-plaque substantive biocide for example, the biguanide chlorhexidine, may also be included in other preferred embodiments of the chewing gum.
- the substantive biocides will also be useful with additional compatible ingredients.
- the lozenge vehicle may be a conventional lozenge base prepared from a tableting lubricant or plasticizer such as glycerine or polyethyleneglycol and powdered sorbitol or a natural or synthetic gum such as gum acacia, tragacanth, guar, psillium and others. It is preferred that enough water be added so that the formula can be partially solubilized, and formulated to be malleable enough for forming a mass, rolled out in a dough-like form and then cut with an appropriate cutter.
- a tableting lubricant or plasticizer such as glycerine or polyethyleneglycol and powdered sorbitol
- a natural or synthetic gum such as gum acacia, tragacanth, guar, psillium and others. It is preferred that enough water be added so that the formula can be partially solubilized, and formulated to be malleable enough for forming a mass, rolled out in a dough-like form and then cut
- Lozenges can also be formulated utilizing powdered sorbitol or a natural or synthetic powdered gum.
- the ingredients to be included may be thoroughly mixed as powders and then compressed, using a tablet forming compression machine.
- flavorants e.g., artificial, non-cariagenic sweeteners such as aspartame, saccharine, cyclamates, and colorants, texturizers, or the like may be employed to impart the desired flavor or color to the lozenge and the other compositions of this invention.
- binders, fillers, and plasticizers are added to produce compositions with the desired uniformity of release of actives by maximally dispersing the active ingredients throughout the delivery vehicle.
- the plasticizers aid to maximize the workability and solubility of the actives in the chewing gum and lozenge base. It is preferred that actives be in a form which can readily solubilize when exposed to saliva without being released too quickly from the release matrices.
- the plasticizers useful in this invention are added to provide the necessary dispersability and solubility of the actives without disturbing the effects of the chewing gum and lozenge release matrix.
- sweeteners, flavorants, colorants, antiseptics, healing agents, and other additives may be advantageously employed to produce a pleasantly palatable formulation with gum healing and soothing activity.
- chewing gum and lozenge compositions of this invention may include antiseptically effective amounts of sodium salicylate and an antiseptically active flavorant for example, thymol eucalytol menthol.
- Natural and artificial sweeteners may also be employed. It is preferred that non-cariagenic sweeteners, for example, saccharin, aspartame, cyclamates or blends of saccharin and aspartame, be used in embodiments of the present application. These non- cariagenic sweeteners provide beneficial flavor characteristics to the chewing gum and lozenge, i.e., promote compliance to use these vehicles, but do not promote the growth of plaque. Cariagenic sweeteners, for example glucose, sucrose, fructose, corn syrup and others well recognized in the art may also be employed in embodiments of the chewing gum formulations. Though useful, these cariagenic sweeteners are less preferred than non-cariagenic sweeteners because they provide nutrients which aid the growth of plaque. Additional non-cariagenic bulk sweeteners that are less potent than the above-mentioned intensive sweeteners, may also be used for example, glycerine and sorbitol.
- non-cariagenic sweeteners for example, saccharin, aspartame
- the chewing gum of this invention is used in a traditional fashion i.e., by chewing the gum and moving it about the teeth by natural jaw and tongue movement with the intention of releasing the actives at a sustained rate for a prolonged period of time .from the chewing gum matrix.
- the lozenge is also utilized in a traditional manner, i.e. by slowly dissolving the tablet in the mouth and washing the teeth with the actives by moving the tongue about the mouth.
- the chewing gum and lozenge compositions of this invention can also be used as the pre-brushing step in conjunction with mouthwash formulations, for example, as described in U.S.S.N. 692,821 of Goldemberg, et al. which is incorporated by reference herein.
- the pH of the compositions of the present invention should be controlled within a particular range of about 4.0 to 10.0 to promote the activity of the anti-plaque compositions of the present invention.
- it will be preferred to employ a pH in the range of about 5.5 to 8.0, and is most preferable to employ a pH range of about 6.0 to 7.0.
- pH may have to be adapted to the other components, for example, the presence of carbon dioxide releasing components in certain embodiments of denture cleansers.
- plaque loosening amounts of a benzoic acid salt and a surfactant may be incorporated into compositions for cleaning surfaces, for example dentures or synthetic or porcelain surfaces outside the oral cavity.
- Denture cleaning compositions are provided in tablet or powder form for addition to water where the surfaces are cleaned. These compositions comprise a surfactant and amounts of a benzoic acid salt effective to remove plaque.
- the formulation may comprise, in addition to a surfactant and effective amounts of salts of benzoic acid, substantive biocides, for example, chlorhexidine, its derivatives and pharmacologically acceptable salts or esters thereof such as 1, I 1 - hexamethylene bis- [5- (4- chlorophenyl) biguanide digluconate.
- salts of perborate or persulfate can be employed such as sodium perborate or sodium persulfate as well as other compounds known to release hydrogen peroxide or other oxidizing agents upon exposure to acidic or basic solutions. These compounds upon release of oxidizing agents after exposure to solution serve to aid the plaque removing ingredients.
- denture cleanser may incorporate disinfectants/antiseptics in combination with the other ingredients. More specifically, formulations of the denture cleanser may include effective amounts of sodium salicylate and sodium borate (borax). Compositions of the present invention may also include sodium borate as a detergent builder, to enhance the detersive effects of the surfactant in the pH range of about 7.0 to 10. Acidic pH ranges may be useful in certain embodiments, depending on the additives that are used. Further preferred embodiments of the denture cleanser may include a combination of an organic acid, for example citric, acetic, malic or tartaric, among others, and salts of bicarbonate.
- an organic acid for example citric, acetic, malic or tartaric, among others, and salts of bicarbonate.
- a preferred organic acid, citric acid is employed to lower the pH of a solution containing the composition to the acidic range and to buffer the aqueous solution.
- Salts of bicarbonate are employed in combination with citric acid to provide an effervescent quality to the cleanser.
- the effervescence provides a physical mixing of the active ingredients which further enhances the anti-plaque effects of the composition.
- any compatible gas emitting substance that produces effervescence upon exposure to a solution can be used.
- a number of additional ingredients utilized in the other aspects of the present invention can also be used, levels depending on the pH and the compatability of the additional ingredients employed.
- the denture cleanser of the present invention may be applied in solutions outside of the mouth.
- the dentures are placed in contact with cleanser solution for as short a time as a few minutes, or alternatively, for a few hours or overnight.
- the dentifrice composition of this invention comprise detersive amounts of an oral surfactant, and at least about 2 percent of an orally compatible salt of benzoic acid in a gel, paste, powder or liquid vehicle.
- dentifrice compositions of the present invention comprise at least about 6% by weight of an effective benzoic acid salt and most preferably between about 6% and 10% by weight of a benzoic acid ⁇ salt-
- a gel carrier is a preferred vehicle of administering the active anti-plaque agents.
- a gel carrier is any group of non-active ingredients that functions to aid introduction of the active ingredients onto the teeth and gums.
- the gel carrier may include water or a solution of water and alcohol (ethanol) . Where employed, the gel carrier may comprise from about 5% to about 98% by weight of the composition but preferably comprises about 65% to 95% by weight of the compositions.
- the oral surfactants employed in the dentifrice, chewing gum and lozenge compositions of this invention are those which are nontoxic and therefore suitable for use in the oral cavity. These provide a detersive effect when they are applied during regular tooth brushing. As explained below, it is preferable to employ a silica, xerogel or silica precipitate abrasive in combination with the oral surfactant but only in the dentifrice compositions of the present invention.
- the oral ionic surfactants are preferred for use as the oral surfactant component, and suitable non- ionic, anionic, amphoteric and cationic surfactants may be employed in the dentrifrice, chewing gum and lozenge formulations. In fact, any surfactant exhibiting strong detersive properties can be used. Denture cleansers of the present invention may employ any number of surfactants, but the oral surfactants are preferred because they may minimize any damage to the surface of the dentures.
- Suitable oral anionic surfactants for use herein include alkyl sulfates such as the soluble nontoxic salts of lauryl sulfate and alkyl sulfonates such as sodium lauryl sulfonate or other sulfonates of alcohols having about 10 to about 18 carbon atoms, as well as N-methyl- N-palmitoyl tauride, or sodium-N- lauroyl sarcosinate or the like. Certain of the anionic surfactants may not be compatible with certain substantive biocide compositions useful in embodiments of the present invention.
- Nonionic oral surfactants which also may be employed herein include mixtures of fatty acid esters of sorbitol and sorbitol anhydrides consisting predominantly of the monoester condensed with about 15 to 25 (e.g. 20) moles of ethylene oxide, such as the commonly available nonionic detergent Tween 20 available fro ⁇ i I.C.I. Americas, Wilmington, Delaware- Other block co-polymers of polyoxyethylene and polyoxypropylene, such as Pluronic F108 available from BASF- Wyandotte Co., Wyandotte, Michigan are useful as well.
- non-ionic organic surface active compounds which are contemplated for use in the present invention include products derived from alkylene oxide condensed with hydrophobic compounds, such as long chain aliphatic alcohols, alkylphenols, carboxamides, sulphonamides, fatty acid amides, and oxyalkylated alcohols. These agents may also function as emulsifiers, humectants and dispersants to provide maximal anti-plaque effect by maintaining the concentration of the active ingredients at anti-plaque levels throughout the dentifrice chewing gum and lozenge composition.
- An additional preferred non-ionic surfactant is polysorbate.
- Additional surfactants including cationic and amphoteric surfactants may also be employed in embodiments of the present invention, provided that compatability requirements with additional agents added to the forumulations are maintained.
- the level of surfactant will, of course , depend on the desired characteristics of the compositions.
- the oral surfactant is preferably employed in the paste, gel, powder, chewing gum and lozenge compositions of the present invention at levels ranging from about .1% to about 10% by weight of the composition, and most preferably from about 0.5% to about 6% of the composition.
- the nonionic detergent is employed at levels sufficient to provide the desired degree of detersive effect or, if desired, foam in the oral cavity during use.
- the compositions of this invention may also include effective amounts of a compatible substantive biocide.
- Preferred substantive biocides for use herein include the bisguanide, chlorhexidine, its derivatives, and pharmacologically acceptable salts or esters thereof, such as l,l'-hexamethylene bis -[5-(4- chlorophenyl) biguanide] digluconate.
- the substantive biocide preferably comprises about 0.005 percent to about 0.75% by weight of the composition.
- anionic surfactants are generally not included because of compatability problems.
- chlorhexidine and sodium lauryl sulfate are generally not used in combination.
- An abrasive is employed in combination with the oral surfactant component of the dentifrice formulations to aid in the removal of stains and plaque on teeth.
- the abrasive compounds used in compositions of the present invention are non-toxic, and orally compatible.
- a number of inorganic salts can be used as abrasives, for example dicalcium phosphate, sodium metaphosphate, calcium pyrophosphate, calcium carbonate, magnesium carbonate, hydrated aluminum oxide, silicates and silicic acid and derivatives thereof.
- care must be taken to avoid the formation of calcium and other insoluble salts of benzoic acid.
- a number of clay materials may be also used as abrasives but the addition of these clay materials may make the clear toothpaste gel form extremely difficult to produce.
- dehydrated silica precipitate abrasives such as ZeodentTM, or Zeo49TM (J.M. Huber Corp., Chemicals Division, Etowaha, Tenn. ) or a silica xerogel abrasive, for example Syloid 74TM (Davison Chemical Division of W.R. Grace Co., Baltimore, MD) are used in the dentifrice compositions because these can be used without affecting formation of gels.
- between about 5 and about 25 percent abrasive by weight of the dentifrice composition is used.
- Formulations of the present invention may include a fumed silica precipitate such as Zeosyl 200 TH , Zeothix 265TM (Huber) or a natural or synthetic clay material such as Laponite XLGTM (LaPorte Industries, Ltd., London, England) or VeegumTM (R.T. (R.T. Vanderbilt, Co., Inc., Norwalk, Conn.) which aid gelling and bulking of the dentifrice, as well as the dispersal of the active ingredients in the dentifrice.
- a fumed silica precipitate such as Zeosyl 200 TH , Zeothix 265TM (Huber) or a natural or synthetic clay material such as Laponite XLGTM (LaPorte Industries, Ltd., London, England) or VeegumTM (R.T. (R.T. Vanderbilt, Co., Inc., Norwalk, Conn.) which aid gelling and bulking of the dentifrice, as well as the dispers
- Bulking and binding agents useful in the dentifrice powders, pastes, gels, chewing gum and lozenge include the natural and synthetic gums such as carboxymethyl cellulose, xanthan gum, gum tragacanth, algin, carrageenan, pectin, gum acacia, karaya, locust bean gum, gum arabic, guar gum, psillium, guince, tamarind and larch.
- Ingredients such as sorbitol that function both as emulsifiers and dispersants may also be employed. Sorbitol is especially useful in formulating lozenges. When sorbitol is used it may comprise about 3% to about 99.5% by weight of the lozenge.
- Plasticizers may also be employed in the compositions of this invention to aid in maximizing the "workability" of the composition of dental surfaces.
- the amount of plasticizer used will be adjusted on the basis of the desired degree of plasticization, other ingredients of the formulation, etc. Any orally compatible plasticizer that is also compatible with the active agents of the formulations of the present invention may be employed. Examples of such plasticizers include the polyethylene glycols, glycerine, and ethyl alcohol.
- plasticizers such as lanolin, stearic acid, sodium and potassium stearate may also be useful, for example, in the range of about 1% to about 30% by weight as well as lecithin, hydrogenated coconut oil, hydrogenated cottonseed oil, mineral oil, olive oil, candelilla wax, paraffin and beeswax.
- sodium benzoate is preferably employed at a level of at least about 1% by weight, and more preferably at a level of at least about 2% by weight of the composition.
- sodium benzoate it is also preferable to employ sodium benzoate at a level of at least about 6% by weight and most preferable to employ sodium benzoate within a range of about 6% to about 10% by weight.
- Plaque consists of about 80% live bacteria in a polysaccharide matrix. It is therefore desirable for a dentifrice to possess significant antibacterial properties in order to eliminate or retard the growth of the bacterial colonies present in plaque.
- the relatively high levels of sodium benzoate employed in embodiments of this invention impart antiseptic properties to the composition.
- additional antiseptics may be included.
- a preferred, antibacterial (and analgesic) additive is sodium salicylate.
- sodium salicylate In addition to, or in place of sodium salicylate, other oral antiseptics which are compatible with the other ingredients of the composition may be employed, for example, benzethenium chloride, N-alkyl- pyridinium chloride, N-cetyl pyridinium bromide, sodium N- lauroyl sarcosine, N- yristoyl glycine and potassium N-lauroyl sarcosine.
- the sodium salicylate or other analgesics preferably comprise about .1 to 6%, and most preferably, about .2 to about 1.0% by weight of the compositions.
- composition of this invention may also include adjuvant ingredients effective to provide the desirable flavoring and coloring, and to impart the desired mouthfeel to the composition.
- the flavorant employed is one which possesses antiseptic properties, e.g. a flavorant based upon thymol, eucalyptol and/or menthol.
- the composition may include the combined antiseptic ingredients sodium benzoate, sodium salicylate and the above-mentioned antiseptic flavorant or an equivalent antiseptic flavorant.
- the concentration of the flavorant is adjusted to impart the desired taste and/or degree of antibacterial activity to the overall formulation.
- alcohol SD38B is employed as a carrier for the flavorants.
- flavorants comprise about 0% to about 4% by weight.
- Sodium bicarbonate may advantageously be employed in the compositions of this invention for purposes of buffering the pH and building the detersive effects of the oral surfactant.
- compositions of this invention may also contain humectants such as glycerine in amounts up to about 50% by weight, or, for example, about 5% to about 45% by weight.
- glycerine functions as a sweetener, and imparts body to the compositions as well as the desired mouthfeel.
- Equivalent materials may be employed in place of, or in combination with glycerine such as sorbitol propylene glycol, and polyethylene glycol.
- the dentifrice is prepared by mixing the active ingredients together to form a homogeneous gel, paste, or powder of the constituent ingredients. The dentifrice is used in a conventional manner, that is, by applying a comfortable amount to the toothbrush, and brushing it about the dental surfaces.
- the same active ingredients used in the dentifrice formulations may be used.
- the chewing gum compositions require a chewing gum base preferably comprising about 5% to about 75% by weight of the final chewing gum product.
- the ingredients referred to as a gum base comprise typical natural and/or synthetic masticatory substances known to the art, for example chicle, crown gum, nispero, rosidinha, jelutong, pondare, tunu, gutta, perillo, synthetic polymers for example polyethylene, polyisobutylene, polyvinylacetate, paraffin, petroleum wax, butadiene-styrene polymer, and isobutylene-isoprene copolymer.
- binders include the aforementioned binders, fillers, sweeteners and flavorants.
- Preferred binders for the chewing gum include the aforementioned natural and synthetic gums gum acacia, carboxymethyl cellulose and other cellulose derivatives both natural and synthetic, algin, carageenan, pectin, tragacanth, karaya, locust bean gum, gum arabic, guar gum, psillium, quince, tamarind and larch.
- binders are used in the chewing gum compositions of this invention, they preferably comprise about 2% to about 80% by weight.
- a particularly useful binder is preferably comprised of a mixture of about 30% to 70% by weight gum acacia in water.
- Preferred fillers useful in the chewing gum of this invention include but are not limited to sorbitol, mannitol or combinations of these ingredients.
- a filler or bulking agent when used comprises from about 4% to about 90% by weight and most preferably comprises about 5% to about 75% by weight.
- a particularly useful combination is comprised of a solution of about 10% to about 80% sorbitol in water and preferably about 45% to about 70% by weight sorbitol in water.
- binders and fillers is important to the sustained administration of the anti- plaque ingredients onto the teeth.
- the amount of binders and fillers utilized will often determine the rate at which the actives are solubilized by saliva and leach ou of the chewing gum matrix to make contact with the plaque-
- flavorants are added.
- the preferred flavorant includes the aforementioned combination of thymol eucalytol and menthol-
- Other preferred flavorants useful in the chewing gum include flavorants well-known in the prior art, for example spearmint, peppermint, fruit flavors, etc.
- the flavorant should comprise about 0.005% to about 5% by weight of the chewing gum.
- sweeteners are also included in preferred embodiments of the lozenge. Preferred sweeteners are those which are non-cariagenic i.e., do not promote the growth of plaque by serving as nutrients.
- Preferred non-cariagenic sweeteners include aspartame, salts of saccharin, and other intense sweeteners.
- sweeteners added depends on the taste desired and the other ingredients added, but usually the sweetener comprises about 0.001% to about 1% by weight.
- Natural, cariagenic sweeteners may also be utilized, but are not preferred. When used, natural cariagenic sweeteners comprise about 5% to about 98% by weight of the compositions.
- Non-cariagenic bulk sweeteners for example glycerine or sorbitol may also be utilized.
- the gum base is prepared by heating and blending the various ingredients in a manner well-known in the art.
- the actives be dissolved or solubilized by plasticizer or water to produce a highly concentrated solution and then the resulting solution added to the gum base.
- the chewing gum compositions of the present invention are used in a conventional manner, i.e. by inserting gum into the mouth and moving the gum about the teeth using jaw and tongue movement.
- the chewing gum compositions can be used in conjunction with a conventional tooth brushing or other oral hygiene method, or as a pre-brushing step.
- the gum can be utilized during "difficult to brush" times to aid in loosening, removing, and preventing plaque buildup.
- the same active ingredients used in the dentifrice and chewing gum compositions are used. It is preferred that artificially sweetened or sugarless lozenges be formulated. In sugarless lozenges, large amounts by weight of binders and/or fillers are generally used.
- binders and/or fillers include sorbitol, mannitol and a number of natural gums preferably for example gum acacia and tragacanth, karaya, or guar gum.
- binders and/or hydrogenated starch hydrolysate fillers comprise about 40% to about 97.7% by weight.
- the lozenge formula is also preferably comprised of a plasticizer or tableting lubricant for example polyethylene glycol, glycerine and other materials aforementioned.
- the plasticizer which aids the mixing and dispersing of the active ingredients before the formulation is tableted preferably comprises about 0.005% to about 5% by weight.
- small amounts of water, preferably about 0-02% to about 5% are added to aid mixing before formulation into tablets.
- the lozenge composition may also be sweetened naturally or artificially with for example, sucrose, corn syrup, saccharin or aspartame.
- the sweeteners may comprise about 40% to about 97.7% by weight of the lozenge.
- artificial sweeteners these comprise about 0.005% to about 1% by weight.
- the same flavorants and amounts of flavorants used in the chewing gums may be used in the lozenge compositions.
- lozenges effective amounts of the active ingredients are combined with a tableting lubricant for example polyethylene glycol, glycerine, or sorbitol or a natural or synthetic gum such as gum acacia or tragacanth.
- a tableting lubricant for example polyethylene glycol, glycerine, or sorbitol or a natural or synthetic gum such as gum acacia or tragacanth.
- lozenges can be formulated utilizing powdered sorbitol or a natural or synthetic gum.
- the ingredients to be formulated are thoroughly mixed in powder form and then compressed using a tablet forming compression machine.
- Lozenges of the present invention are utilized in a conventional manner, i.e. by slowly dissolving in the mouth upon exposure to saliva.
- the active ingredients bathe the teeth and can reach hard to reach surfaces by being washed about the teeth by the tongue of the user.
- These formulations can also be used in conjunction with a usual toothbrushing or oral hygiene method.
- the lozenges of the present invention can be used before brushing with a conventional toothbrush or after brushing to aid in the removal and prevention of plaque buildup.
- the same surfactants used in the oral dentifrice may be used.
- surfactants other than orally compatible surfactants can be used, but it is preferred that oral surfactants be used to maximize plaque removal without damaging the denture surfaces.
- Sodium lauryl sulfate is a particularly preferred oral surfactant useful in this invention.
- Surfactants are useful in a range from about 0.1% to 10% by weight of the composition, and are most preferable in a range of about 0.5 to about 10% of the composition. Of course, the amount of surfactant can be adjusted to provide the desired detersive action.
- Salts of benzoic acid or benzoic acid analogues are also used in the denture cleanser aspect of this invention. At least about 1% by weight of a salt of benzoic acid or an analogue of benzoic acid is useful, and preferably at least about 4% to about 15% by weight of sodium benzoate is used.
- a nascent oxygen containing compound is preferably included i compositions of the denture cleanser of the present invention to aid in removing stains present on dentures.
- salts of perborate and/or persulfate are used in the range of from about 2% to 25% by weight and preferably about 5% to about 17% by weight. Any water soluble perborate or persulfate salt can be used in the composition, but it is preferred that sodium perborate or persulfate be used.
- the denture cleanser antiseptics such as those previously described herein, for example salicylate, as well as other ingredients for example, salts of boric acid and allantoin are added to the formulations.
- Any effective amount of sodium salicylate can be used, but it is preferred that sodium salicylate be used in a range from about 0.2 to 6% by weight. It is preferred that the sodium salt of borate be used at a concentration from about 0.2 to 10% by weight.
- allantoin can be used at a concentration of about 0.1% to about 3% by weight of the composition to disperse the protein film of plaque and aid plaque removed.
- An organic acid and a compatible gas releasing composition are preferably employed in combination to provide an effervescent quality to solutions of the denture cleanser.
- Preferable organic acids that may be employed in the denture cleanser of this invention include acetic acid, citric acid, malic acid, and tartaric acid, among others. Citric acid is most preferred.
- the organic acid should be employed in concentrations sufficient to lower the pH of aqueous solutions of the dental cleanser sufficiently to release carbon dioxide from a gas releasing composition such as a salt of carbonic acid or bicarbonate.
- the pH is in the range of about 4.0 to about 10. It is preferred that a pH of 5.5 to 8.0 be utilized and most preferable at a pH of 6.0 to 7.0 be used. The pH of course, may be higher or lower depending upon the other components of the compositions employed. In certain embodiments of denture cleansers the pH may have to be lowered to accommodate gas releasing components.
- Sodium bicarbonate is the preferred gas- releasing component. The preferred concentration of sodium bicarbonate is that which provides sufficient effervescent activity in combination with citric acid to create a mixing action which aids plaque removal, preferably about 20% to about 50% by weight.
- a pH of between about 5.5 and 8 is preferably employed. though any pH compatible with oral use may be utilized.
- Bulking agents can also be used in certain preferred embodiments, along with buffers and preservatives-
- a particularly effective compound exhibiting bulking and buffering, activities is trisodium hydrogen phosphate, but any of the water soluble phosphates may be used. Additionally a large number of neutral salts can function as the bulking agent, for example sodium and potassium chloride.
- the denture cleanser may be prepared by mixing the active ingredients into a homogeneous powder. The powder may be packaged and used as such, or may be formulated in pre-measured tablet form. The denture cleanser is used in a conventional manner; that is, by dissolving a recommended quantity in water, and exposing the dentures to the solution for a period sufficient to clean the dentures and remove plaque, generally overnight.
- Phase A Carboxymethyl cellulose is sprinkled into glycerine in the amounts listed with agitation until fully mixed.
- Phase A In a separate vessel phase B ingredients except Carbowax are heated to 75°C. Carbowax #1540 is premelted and added to the phase B ingredients at 75°C until all the ingredients are dissolved.
- Phase B to Phase A with agitation. Place the mixed Phases A plus B under vacuum for 15 minutes with mixing.
- Add half of the ZEOTHIX 265 with mixing. Mix Phases A, B, C and D under vacuum. Add the other half of Phase D with mixing. Vacuum this mixture for 15 minutes.
- Phase E is made by sprinkling sodium lauryl sulfate into the glycerine with agitation. The remaining ingredients of Phase E are added with agitation. After complete mixing phase E is added to Phases A, B, C and D with agitation to produce a gel dentifrice.
- Procedure Pre-weigh all the ingredients of phase B flavor except flavor and mix flavor except flavor with agitation. Heat this mixture to 60°C and agitate to dissolve all the ingredients. After these ingredients are dissolved, then add the flavor. Pre-mix all the ingredients of phase A at room temperature at high speed. Add phase B ingredients. Mix at room temperature on low speed and mix for an additional time period until a gel ⁇ like product is formed. Put the thoroughly mixed product into an oven at 45 ⁇ C for 72 hours.
- PLASTICIZER about 1% to about 20%
- ALLANTOIN about 0-1% to about 3%
- Procedure Mix all the ingredients together to form a homogeneous powder. The powder can then be packaged, or formulated into tablets.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Les compositions dentifrices décrites comprennent des compositions contenant des quantités détergentes d'un agent tensio-actif oral et au moins un pourcent en poids d'un sel d'acide benzoïque ou un dérivé dudit sel efficaces pour combattre les plaques se trouvant à la surface des dents. La combinaison des ingrédients actifs est particulièrement efficace contre les plaques lorqu'ils sont inclus dans les compositions décrites. Celles-ci comprennent un véhicule dentifrice comprenant au moins un pourcent en poids d'un sel d'acide benzoïque et des quantités détergentes d'un agent tensio-actif oral. Dans un mode de réalisation préféré, on utilise une pâte dentifrice contenant comme ingrédient actif au moins 6 % environ en poids d'un sel d'acide benzoïque. Le véhicule peut être une pâte, un gel ou toute autre substance analogue pouvant s'appliquer sur une brosse à dents et être utilisé pour le brossage des dents. Les compositions pulvérulentes de la présente invention sont conçues pour le brossage des dents dans la cavité de la bouche ou pour le brossage de prothèses dentaires mobiles ou autre surface synthétique à l'extérieur de la cavité de la bouche.The dentifrice compositions described comprise compositions containing detergent amounts of an oral surfactant and at least one percent by weight of a benzoic acid salt or a derivative of said salt effective in combating plaques on the surface of teeth. The combination of the active ingredients is particularly effective against plaques when they are included in the compositions described. These include a toothpaste vehicle comprising at least one percent by weight of a benzoic acid salt and detergent amounts of an oral surfactant. In a preferred embodiment, a toothpaste containing as active ingredient at least about 6% by weight of a benzoic acid salt is used. The vehicle can be a paste, a gel or any other similar substance which can be applied to a toothbrush and can be used for brushing teeth. The powder compositions of the present invention are designed for brushing teeth in the mouth cavity or for brushing movable dental prostheses or other synthetic surface outside the mouth cavity.
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88462586A | 1986-07-11 | 1986-07-11 | |
| US884625 | 1997-06-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0273962A1 true EP0273962A1 (en) | 1988-07-13 |
| EP0273962A4 EP0273962A4 (en) | 1988-07-27 |
Family
ID=25385011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19870904629 Withdrawn EP0273962A4 (en) | 1986-07-11 | 1987-07-10 | Compositions for the prolonged action of anti-plaque agents. |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0273962A4 (en) |
| JP (1) | JPH01501472A (en) |
| AU (1) | AU7694787A (en) |
| WO (1) | WO1988000463A1 (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994262A (en) * | 1988-10-14 | 1991-02-19 | The Procter & Gamble Company | Oral compositions |
| FR2647308A1 (en) * | 1989-08-22 | 1990-11-30 | Maestre Reyes Jose | Chewing-gum composition and manufacturing method |
| EP0414932A1 (en) * | 1989-08-29 | 1991-03-06 | Csemege Edesipari Gyar | Chewing gum composition |
| US4992256A (en) * | 1989-09-27 | 1991-02-12 | Colgate-Palmolive Company | Plaque disclosing compositions |
| US5028413A (en) * | 1990-03-21 | 1991-07-02 | Bausch & Lomb Incorporated | Novel fluoride-containing dentifrice |
| DE4222739A1 (en) * | 1992-07-10 | 1994-01-13 | Henkel Kgaa | Liquid dentifrices |
| EP0666731B1 (en) * | 1992-10-28 | 2004-09-15 | Den-Mat Corporation | Antibacterial mouthwash |
| US6485739B2 (en) | 2000-03-10 | 2002-11-26 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
| US6471945B2 (en) | 2000-03-10 | 2002-10-29 | Warner-Lambert Company | Stain removing chewing gum and confectionery compositions, and methods of making and using the same |
| US7041277B2 (en) | 2000-03-10 | 2006-05-09 | Cadbury Adams Usa Llc | Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same |
| US7445769B2 (en) | 2002-10-31 | 2008-11-04 | Cadbury Adams Usa Llc | Compositions for removing stains from dental surfaces and methods of making and using the same |
| US7658959B2 (en) | 2003-06-12 | 2010-02-09 | Cargill, Incorporated | Antimicrobial salt solutions for food safety applications |
| US7588696B2 (en) | 2003-06-12 | 2009-09-15 | Cargill, Incorporated | Antimicrobial water softener salt and solutions |
| US7090882B2 (en) | 2003-06-12 | 2006-08-15 | Cargill, Incorporated | Antimicrobial salt solutions for food safety applications |
| US7883732B2 (en) | 2003-06-12 | 2011-02-08 | Cargill, Incorporated | Antimicrobial salt solutions for cheese processing applications |
| US7390518B2 (en) | 2003-07-11 | 2008-06-24 | Cadbury Adams Usa, Llc | Stain removing chewing gum composition |
| US9271904B2 (en) | 2003-11-21 | 2016-03-01 | Intercontinental Great Brands Llc | Controlled release oral delivery systems |
| US7641892B2 (en) | 2004-07-29 | 2010-01-05 | Cadburry Adams USA, LLC | Tooth whitening compositions and delivery systems therefor |
| US7727565B2 (en) | 2004-08-25 | 2010-06-01 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
| US9198448B2 (en) | 2005-02-07 | 2015-12-01 | Intercontinental Great Brands Llc | Stable tooth whitening gum with reactive ingredients |
| US8486472B2 (en) | 2006-01-18 | 2013-07-16 | Cargill, Incorporated | Antimicrobial salt solutions for food safety applications |
| JP5209864B2 (en) * | 2006-10-20 | 2013-06-12 | 花王株式会社 | Biofilm formation inhibitor composition |
| JP2008100964A (en) * | 2006-10-20 | 2008-05-01 | Kao Corp | Biofilm formation inhibitor composition |
| KR101384328B1 (en) | 2006-03-23 | 2014-04-10 | 가오 가부시키가이샤 | Bacterial Film Formation Inhibitor Composition |
| BRPI0710245A2 (en) | 2006-04-05 | 2011-08-09 | Cadbury Adams Usa Llc | Impact of calcium phosphate complex on dental caries |
| ES2619161T3 (en) | 2006-04-05 | 2017-06-23 | Intercontinental Great Brands Llc | Complex of calcium phosphate and salts in oral delivery systems |
| DE102012007212A1 (en) | 2012-04-11 | 2013-10-17 | Merz Pharma Gmbh & Co. Kgaa | Preparation for topical application to mucous membranes with polyhexanide as active ingredient |
| WO2015151915A1 (en) * | 2014-03-31 | 2015-10-08 | ライオン株式会社 | Toothpaste composition |
| WO2025093531A1 (en) * | 2023-11-01 | 2025-05-08 | Unilever Ip Holdings B.V. | Oral care composition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1627963A (en) * | 1920-01-30 | 1927-05-10 | Henry C Fuller | Medicinal product |
| FR737220A (en) * | 1931-09-03 | 1932-12-08 | Henkel & Cie Gmbh | Toothpaste and oral hygiene product |
| SE321765B (en) * | 1968-11-29 | 1970-03-16 | K Holmstroem | |
| US4152418A (en) * | 1970-04-01 | 1979-05-01 | Lever Brothers Company | Zinc and enzyme mouthwash and mouthwash concentrate for reducing dental plaque and calculus formation |
| US3772431A (en) * | 1972-09-21 | 1973-11-13 | W Mlkvy | Effervescent mouthwash tablet |
| US3887701A (en) * | 1974-11-01 | 1975-06-03 | Colgate Palmolive Co | Antibacterial oral compositions containing preservative-antioxidants |
| GB2095694B (en) * | 1981-03-31 | 1984-08-01 | Hollaway E R Ltd | Tooth cleaning compositions |
| US4362639A (en) * | 1981-04-03 | 1982-12-07 | Warner-Lambert Company | Cleanser with improved afterodor and tarnish resistance |
| US4666708A (en) * | 1984-01-27 | 1987-05-19 | Oral Research Laboratories, Inc. | Dental rinse |
| US4585649A (en) * | 1984-12-21 | 1986-04-29 | Ici Americas Inc. | Dentifrice formulation and method of treating teeth, mouth and throat therewith to reduce plaque accumulation and irritation |
-
1987
- 1987-07-10 JP JP62504295A patent/JPH01501472A/en active Pending
- 1987-07-10 EP EP19870904629 patent/EP0273962A4/en not_active Withdrawn
- 1987-07-10 WO PCT/US1987/001640 patent/WO1988000463A1/en not_active Ceased
- 1987-07-10 AU AU76947/87A patent/AU7694787A/en not_active Abandoned
Non-Patent Citations (2)
| Title |
|---|
| No relevant documents have been disclosed. * |
| See also references of WO8800463A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01501472A (en) | 1989-05-25 |
| AU7694787A (en) | 1988-02-10 |
| EP0273962A4 (en) | 1988-07-27 |
| WO1988000463A1 (en) | 1988-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0273962A1 (en) | Compositions for the prolonged action of anti-plaque agents | |
| US4657758A (en) | Dental rinse | |
| EP0169888B1 (en) | Dental rinse | |
| JP2927850B2 (en) | Topical preparations for the treatment of symptoms of teeth and their supporting tissues | |
| US6610276B2 (en) | Multi-functional dental composition | |
| EP0421838B1 (en) | Method of making dental plaque observable | |
| KR890002946B1 (en) | Oral hygine compositions | |
| US10058497B2 (en) | Oral hygiene products and method of using the same | |
| US7592025B2 (en) | Vehicles for oral care with magnolia bark extract | |
| US20030003059A1 (en) | Dentifrice compositions | |
| US20070237806A1 (en) | Multi-functional dental composition | |
| JPH0784374B2 (en) | Anti-tartar toothpaste | |
| JP2005503402A (en) | Oral compositions that provide enhanced overall cleansing | |
| IE58745B1 (en) | Oral compositions | |
| US8303938B2 (en) | Anti-calculus dental composition | |
| JPH07108851B2 (en) | Oral composition for preventing solid pimples | |
| AU2004251729A1 (en) | Antiplaque confectionery dental composition | |
| JP2548265B2 (en) | Oral hygiene medicine | |
| US20190167544A1 (en) | Dual Compnent Oral Composition for Enhancing Remineralization of Teeth | |
| WO1987005501A1 (en) | Treatment of dental surfaces with plaque retardants | |
| US20190008746A1 (en) | Oral Hygiene Products and Method of Using the Same | |
| JP2001002542A (en) | Oral composition | |
| JP2002020254A (en) | Dentifrice composition | |
| KR102704685B1 (en) | Liquid toothpaste composition with improved breakage | |
| KR102820075B1 (en) | Solid toothpaste of tablet type |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19880323 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19880727 |
|
| EL | Fr: translation of claims filed | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PFIZER INC. |
|
| 17Q | First examination report despatched |
Effective date: 19900802 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19901213 |